Quality of life in relation to constipation among opioid users

Journal of Medical Economics

Volumn 13, Issue 1, 2010, Pages 129-135

  Penning Van Beest, Fernie J A ^a   Van Den Haak, Pieter ^a   Klok, Rogier M ^b   Prevoo, Yves F D M ^b   Van Der Peet, Donald L ^c   Herings, Ron M C ^a,d  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b Wyeth Pharmaceuticals BV   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Constipation; Opioid; Quality of life; Questionnaires

Indexed keywords

FENTANYL; LAXATIVE; MORPHINE; OPIATE; OXYCODONE; TRAMADOL;

ADULT; ARTICLE; BACKACHE; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM;

ADAPTATION, PSYCHOLOGICAL; ANALGESICS, OPIOID; CONSTIPATION; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PAIN; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL;

EID: 77149137752     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990903584436     Document Type: Article

References (21)

1. World Health Organization. WHO's pain ladder. Available at: www.who.int/cancer/palliative/painladder/en/index.html.
2. Quigley C. The role of opioids in cancer pain. BMJ 2005;331: 825-829.
3. Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007;61:1181-1187.
4. Holzer P. Treatment of opioid-induced gut dysfunction. Expert Opinlnvestig Drugs 2007;16:181-194.
5. Nederlands Huisartsen Genootschap. Farmacotherapeutische Richtlijn Pijnbestrijding. Oktober 2007. Available at: nhg.artsen-net.nl/upload/104/ standaarden/FTR/Pijnbestrijding.html.
6. van Schieveen S, Kramer P. Omgaan met obstipatie door sterke pijnmedicatie. Onderzoek onder patiënten en mantelzorgers. Available at: http://www.dubbelop.info/Portals/2/multimedia/TNSNIPOOmgaanmetoic.pdf.
7. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-380.
8. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005;7:R1046-1051.
9. McMillan SC. Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control 2004;11:3-9.
10. Cook SF, Lanza L, Zhou X, et al. Gastrointestinal side effects in chronic opioid users: results from a population-based survey. Aliment Pharmacol Ther 2008;27:1224-1232.
11. Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005;23:461-476.
12. Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther 2007;26:227-236.
13. Bell TJ, Panchal SJ, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Med 2009;10:35-42.
14. Slappendel R, Simpson K, Dubois D, Keininger DL. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain 2006;10: 209-217.
15. Marquis P, De La Loge C, Dubois D, et al. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol 2005;40:540-551.
16. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208.
17. Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993;2:169-180.
18. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
19. World Health Organization. Symptom relief in terminal illness. Geneva: World Health Organization, 1998;24-33.
20. Fakata KL, Cole BE. Peripheral opioid antagonists: a therapeutic advance for optimizing opioid gastrointestinal tolerability. J Fam Pract 2007;56:S3-12.
21. Moss J, Rosow CE. Development of peripheral opioid antagonists' new insights into opioid effects. Mayo Clin Proc 2008;83: 1116-1130.